Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Stefanie, Kube"'
Autor:
Stefanie Kube, Christian Vokuhl, Tobias M. Dantonello, Felix Niggli, Monika Scheer, Ewa Koscielniak, Thomas Klingebiel, Simone Feuchtgruber, Ingrid Kuehnle, Gabriele Escherich, Stefan S. Bielack, Erika Hallmen, Thekla von Kalle
Publikováno v:
Pediatric bloodcancer. 65(6)
Background Inflammatory myofibroblastic tumors (IMTs) are a rare subgroup of soft tissue tumors. The outcome of patients with IMT has been reported as favorable when the tumor is completely resected. If surgical resection is not possible, systemic th
Autor:
Gustaf Ljungman, Beate Timmermann, Rudolf Hagen, Stefanie Kube, Daniel Kosztyla, Rupert Handgretinger, Simone Feuchtgruber, Thomas Klingebiel, Tobias M. Dantonello, Felix Niggli, Ruth Ladenstein, Monika Stark, Bernarda Kazanowska, Ewa Koscielniak, Jörg Fuchs, Barbara Selle, Stefan S. Bielack, Christin Linderkamp
Publikováno v:
Pediatric Blood & Cancer. 62:16-23
Background Response (tumour volume reduction) to induction chemotherapy has been used to stratify secondary local and systemic treatment of Intergroup Rhabdomyosarcoma Study Group III (IRSG-III) embryonal rhabdomyosarcoma (RME) in consecutive CWS-tri
Autor:
Cooperative Weichteilsarkom Studiengruppe, Tobias M. Dantonello, Stefanie Kube, Bernarda Kazanowska, Thomas Klingebiel, Paul-Gerhardt Schlegel, Gustaf Ljungman, Guido Seitz, Christoph Int-Veen, Iris Veit-Friedrich, Michaela Nathrath, Stefan S. Bielack, Ivo Leuschner, Ewa Koscielniak, Udo Kontny, Ruth Ladenstein, Erika Hallmen, Wolfgang Behnisch, Michael Paulussen, Andreas Schuck
Publikováno v:
Pediatric Blood & Cancer. 60:1267-1273
Recurrences in primary localized alveolar rhabdomyosarcoma (RMA) are common. Post-relapse survival is poor. We evaluated prognostic factors including relapse treatment in patients with recurrent RMA.Relapses occurred in 115/235 patients with nonmetas
Autor:
Niklas Pal, B Bernbeck, Michaela Nathrath, Gustaf Ljungman, Peter Kaatsch, Cws, Christian Vokuhl, Tobias M. Dantonello, Ewa Koscielniak, Ivo Leuschner, Thomas Klingebiel, Stefan S. Bielack, Andreas Schuck, Stefan Gfroerer, Stefanie Kube
Publikováno v:
Pediatric Blood & Cancer. 60:224-229
Malignant ectomesenchymoma (MEM) is a soft tissue tumor with heterologous rhabdomyoblastic components believed to arise from pluripotent migratory neural crest cells. To date merely 50 cases have been published and the knowledge about the course of d
Autor:
Tobias M, Dantonello, Monika, Stark, Beate, Timmermann, Jörg, Fuchs, Barbara, Selle, Christin, Linderkamp, Rupert, Handgretinger, Rudolf, Hagen, Simone, Feuchtgruber, Stefanie, Kube, Daniel, Kosztyla, Bernarda, Kazanowska, Ruth, Ladenstein, Felix, Niggli, Gustaf, Ljungman, Stefan S, Bielack, Thomas, Klingebiel, Ewa, Koscielniak
Publikováno v:
Pediatric bloodcancer. 62(1)
Response (tumour volume reduction) to induction chemotherapy has been used to stratify secondary local and systemic treatment of Intergroup Rhabdomyosarcoma Study Group III (IRSG-III) embryonal rhabdomyosarcoma (RME) in consecutive CWS-trials. To eva
Autor:
Erik Sköldenberg, Iris Veit-Friedrich, Thomas Klingebiel, Helmut Lochbühler, Tobias M. Dantonello, Erika Hallmen, Markus Franke, Stefan S. Bielack, Jan Godzinski, Ewa Koscielniak, Andreas Schuck, Gustaf Ljungman, Stefanie Kube, Daniel Kosztyla, R. Wessalowski, Simone Feuchtgruber
Publikováno v:
Annals of surgical oncology. 21(11)
Embryonal rhabdomyosarcoma is the most common pediatric soft tissue sarcoma. The best local treatment in large, nonmetastatic primary unresected nongenitourinary embryonal rhabdomyosarcoma of the abdomen (LARME) is however unclear.We analyzed patient
Autor:
Tobias M, Dantonello, Christoph, Int-Veen, Andreas, Schuck, Guido, Seitz, Ivo, Leuschner, Michaela, Nathrath, Paul-Gerhardt, Schlegel, Udo, Kontny, Wolfgang, Behnisch, Iris, Veit-Friedrich, Stefanie, Kube, Erika, Hallmen, Bernarda, Kazanowska, Ruth, Ladenstein, Michael, Paulussen, Gustaf, Ljungman, Stefan S, Bielack, T, Klingebiel, E, Koscielniak
Publikováno v:
Pediatric bloodcancer. 60(8)
Recurrences in primary localized alveolar rhabdomyosarcoma (RMA) are common. Post-relapse survival is poor. We evaluated prognostic factors including relapse treatment in patients with recurrent RMA.Relapses occurred in 115/235 patients with nonmetas
Autor:
Tobias M, Dantonello, Ivo, Leuschner, Christian, Vokuhl, Stefan, Gfroerer, Andreas, Schuck, Stefanie, Kube, Michaela, Nathrath, Benedikt, Bernbeck, Peter, Kaatsch, Niklas, Pal, Gustaf, Ljungman, Stefan S, Bielack, Thomas, Klingebiel, Ewa, Koscielniak
Publikováno v:
Pediatric bloodcancer. 60(2)
Malignant ectomesenchymoma (MEM) is a soft tissue tumor with heterologous rhabdomyoblastic components believed to arise from pluripotent migratory neural crest cells. To date merely 50 cases have been published and the knowledge about the course of d
Autor:
Rupert Handgretinger, Ivo Leuschner, Ruediger Fengler, Stefanie Kube, Daniel Kosztyla, Gustaf Ljungman, Iris Veit-Friedrich, Felix Niggli, Thekla von Kalle, Tobias M. Dantonello, Stefan S. Bielack, Peter Kaatsch, Ewa Koscielniak, Peter Winkler, Thomas Klingebiel
Publikováno v:
Journal of Clinical Oncology. 30:9573-9573
9573 Background: Most patients with pediatric soft tissue sarcoma (PSTS) achieve a 1st remission with primary therapy, but recurrences are frequent and drive mortality. Relapse detection (RD) is the foundation of post-treatment surveillance. The rati